Pharmacy Times

JULY 16, 2025

Tarlatamab established a new standard for relapsed SCLC, with improved survival and easier administration, enhancing treatment accessibility. NALIRIFOX regimen showed improved overall survival in pancreatic cancer, underscoring the importance of dose optimization and toxicity management.

HIV Treatment and Prevention Agents 26

HIV Treatment and Prevention Agents Pharmacy Technician Diabetes Compounding Pharmacies 26

Pharmacy Times

JUNE 16, 2025

Transportation barriers, as a health-related social need, significantly impact FN rates in chemotherapy patients. Febrile neutropenia (FN) remains a serious and common complication of chemotherapy. A 67% FN rate difference between pegfilgrastim and filgrastim was observed in patients with transportation barriers.

Inpatient 29

Inpatient HIV Treatment and Prevention Agents Pharmacy Technician Chemotherapy 29

Pharmacy Times

JUNE 10, 2025

3 Although meloxicam injection delivers a non-opioid alternative for pain control, it is not recommended as a first-line agent when rapid onset of analgesia is needed due to its delayed onset. 2 REFERENCES 1. Meloxicam: Selective COX-2 inhibition in clinical practice. Seminars in Arthritis and Rheumatism. December 21, 2004. Subscribe Now!

Pharmacy Technician 29

Pharmacy Technician HIV Treatment and Prevention Agents Compounding Pharmacies Biosimilars 29